Timothy Walbert

Walbert has been president and CEO since 2008 and chairman since 2010. Prior to Horizon, he was president, CEO and director of IDM Pharma Inc., served as EVP of commercial operations at NeoPharm Inc., and divisional VP and general manager of immunology at Abbott, now AbbVie, where he led the global development and launch of the multi-indication biologic HUMIRA.